Publication

Byline

Credo Brands Marketing to hold board meeting

Mumbai, Oct. 29 -- Credo Brands Marketing will hold a meeting of the Board of Directors of the Company on 4 November 2026. Published by HT Digital Content Services with permission from Capital Market... और पढ़ें


iQOO Neo 12 : 9000ఎంఏహెచ్​ బ్యాటరీతో కొత్త గేమింగ్ స్మార్ట్​ఫోన్ లాంచ్- ఐక్యూ నియో 12 ధర, ఫీచర్లు..

భారతదేశం, అక్టోబర్ 29 -- స్మార్ట్‌ఫోన్ ప్రియులు, ముఖ్యంగా గేమింగ్ లవర్స్ ఎప్పుడెప్పుడా అని ఆసక్తిగా ఎదురుచూస్తున్న 'ఐక్యూ నియో 12' చైనా మార్కెట్​లోకి అధికారికంగా అడుగుపెట్టింది. గతంలో వచ్చి మంచి విజయా... और पढ़ें


Thakurgaon BNP candidate eyes big win

Dhaka, Oct. 29 -- BNP candidate Mirza Faisal Amin, the younger brother of President Mirza Fakhrul Islam Alamgir, has voiced hope of a big win in the Thakurgaon by-election. After casting his vote at ... और पढ़ें


Lee Kuan Yew Global Business Plan Competition Opens Global Search for Deep Tech Urban Solutions and Sustainability focused Founders

Bhubaneswar, Oct. 29 -- Finalists compete for over S$2.5 million (US$2 million) in prizes and gain a pathway to SMU's Urban SustaInnovator accelerator and US$10 million USI Fund Grand Finalists from ... और पढ़ें


SC refuses to order 'full public disclosure' of ultimate beneficiaries of AIFs, FPIs without 'legal framework'

New Delhi, Oct. 29 -- The Supreme Court on Thursday refused to direct the Securities and Exchange Board of India (SEBI) to mandate full public disclosure of the details of ultimate beneficial owners (... और पढ़ें


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... और पढ़ें


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... और पढ़ें


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... और पढ़ें


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, Oct. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... और पढ़ें